Highlights
The Global technical strategy for malaria 2016–2030 was adopted by the World Health Assembly in May 2015. It provides a comprehensive framework to...
In 2021, preliminary results of observational studies from the Community Access to Rectal Artesunate for Malaria (CARAMAL) project did not confirm the...
WHO has recommended rectal artesunate (RAS) as an effective pre-referral treatment for severe malaria since 2006. On 18-19 October 2022, WHO convened a...
A WHO meeting on the regional response to the invasion of Anopheles stephensi in Africa was held in Addis Ababa, Ethiopia on 8–10 March 2023. This...
On 18–20 April 2023, the WHO Malaria Policy Advisory Group (MPAG) convened to review updates and progress, and to provide guidance on thematic areas...
Seasonal malaria chemoprevention (SMC) is the intermittent administration of a curative dose of antimalarial medicine to children at high risk of severe...
Preferred product characteristics (PPCs) are key tools to incentivize and guide the development of urgently needed health products. The PPCs published...